What does CervoMed, Inc. do?
CervoMed, Inc. is a clinical-stage biotechnology company focused on developing cancer treatments that improve radiation and chemotherapy effectiveness by targeting tumor oxygen deprivation. It has a market cap of $61.44 million, with recent net sales of $2 million and a net loss of $5 million.
Overview: CervoMed, Inc. is a clinical-stage biotechnology company focused on developing treatments for cancer, specifically targeting tumor oxygen deprivation to enhance the effectiveness of radiation therapy and chemotherapy. The company operates in the Miscellaneous industry and falls within the micro-cap market bracket.Financial Snapshot:
Most recent Net Sales: 2 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -5 Million (Quarterly Results - Mar 2025)
Market-cap: USD 61.44 Million (Micro Cap)
Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.02
Return on Equity: -53.91%
Price to Book: 1.77
Contact Details:
Address: 2020 Avon Ct Ste 4, CHARLOTTESVILLE VA : 22902-8734
Tel: 1 434 2200718
Fax: 1 434 2200722
Website: https://diffusionpharma.com/
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
